Table 1.
Subject Characteristics | Pediatric Subjects |
Adult Subjects |
||||
---|---|---|---|---|---|---|
Positive NTM (n = 48) | 2005 Pediatric CF Center, Negative NTM (n = 451) | Positive NTM vs. Negative NTM | Positive NTM (n = 48) | 2005 Adult CF Center, Negative NTM (n = 103) | Positive NTM vs. Negative NTM | |
Age, median yr (IQR) | 12.9 (11.4–14.5) | 11.2 (6.0–17.1) | P = 0.16 | 26.4 (21.0–34.2) | 32.3 (25.6–39.8) | P < 0.01* |
Female sex, n (%) | 24 (50) | 216 (48) | P = 0.78 | 27 (56) | 61 (59) | P = 0.73 |
FEV1% predicted, mean (SD) | 89% (19.6) | 88% (23.8) | P = 0.66 | 71% (22.0) | 58% (23.7) | P < 0.01* |
Pediatric BMI percentile, median (IQR) | 29.5th (12.0–53.0) | 40.9th (21.5–63.4) | P = 0.02* | — | — | |
Adult BMI, median (IQR) | — | — | 21.3 (19.1–24.1) | 21.0 (19.0–23.8) | P = 0.06 | |
Azithromycin use, n (%) | 15 (31) | N/A | N/A | 18 (38) | N/A | N/A |
Macrolide resistant NTM, n (%) | 4 (8) | 7 (15) | ||||
CF genotype, n (%) | P = 0.24 | P = 0.01* | ||||
F508del homozygous | 29 (61) | 221 (49) | 20 (42) | 50 (49) | ||
F508del heterozygous | 15 (31) | 159 (35) | 25 (52) | 43 (42) | ||
Other | 4 (8) | 45 (10) | 3 (6) | 6 (6) | ||
Unknown | 0 (0) | 26 (6) | 0 (0) | 4 (4) | ||
Coinfection, n (%) | ||||||
Staphylococcus aureus (any) | 35 (73) | 296 (69) | P = 0.30 | 34 (72) | 47 (51) | P < 0.01* |
Pseudomonas aeruginosa (any) | 16 (33) | 174 (41) | P = 0.47 | 26 (55) | 67 (73) | P = 0.20 |
Stenotrophomonas maltophilia | 14 (29) | 49 (12) | P < 0.001* | 10 (21) | 8 (9) | P = 0.02* |
Aspergillus fumigatus | 18 (38) | 72 (17) | P < 0.001* | 14 (30) | 7 (8) | P < 0.001* |
NTM type isolated, n (%): | ||||||
MAC | 36 (75) | N/A | N/A | 33 (69) | N/A | N/A |
M. abscessus | 10 (21) | 13 (27) | ||||
MAC and M. abscessus | 1 (2) | 0 (0) | ||||
Other | 1 (2) | 2 (4) |
Definition of abbreviations: BMI = body mass index; IQR = interquartile range; MAC = Mycobacterium avium complex; N/A = not available; NTM = nontuberculous mycobacteria
Statistically significant correlations.